Clinical Implications of Non-A-Type<i> NPM1</i> and <i>FLT3</i> Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Acta Haematol 2012;127:63–71.

Slides:

Advertisements

Similar presentations

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group by Phoenix.

Advertisements

Case 255 Elizabeth Courville, MD Robert Hasserjian, MD Massachusetts General Hospital Society for Hematopathology/European Association for Haematopathology.

Margaret L. Gulley, Thomas C. Shea, Yuri Fedoriw

Echocardiographic Changes in Patients with Stage 3-5 Chronic Kidney Disease and Left Ventricular Diastolic Dysfunction Cardiorenal Med 2014;4:

Aesthet Dermatol Surg 2017;1:2–7 - DOI: /

Triple Negative Breast Cancer versus Non-Triple Negative Breast Cancer Treated with Breast Conservation Surgery Followed by Radiotherapy: A Systematic.

Puberty and Ovarian Function in Girls with Type 1 Diabetes Mellitus

Paroxetine, Cognitive Therapy or Their Combination in the Treatment of Social Anxiety Disorder with and without Avoidant Personality Disorder: A Randomized.

Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias Acta.

Type 1 Diabetes Duration Decreases Pulmonary Diffusing Capacity during Exercise Respiration 2016;91: DOI: / Fig. 1. DLCO/BSA at.

Qualitative and Quantitative Issues of Lymph Nodes as Prognostic Factor in Colon Cancer Dig Surg 2013;30: DOI: / Fig. 1. Multiple.

Follicular Cell-Derived Thyroid Cancer in Children

Renalase, a Novel Enzyme Involved in Blood Pressure Regulation, Is Related to Kidney Function but Not to Blood Pressure in Hemodialysis Patients Kidney.

A Retrospective Multicentre Cohort Review of Patient Characteristics and Surgical Aspects versus the Long-Term Outcomes for Recipients of a Fully Implantable.

Case Rep Oncol 2017;10:462– DOI: /

Are Sodium Transporters in Urinary Exosomes Reliable Markers of Tubular Sodium Reabsorption in Hypertensive Patients? Nephron Physiol 2010;114:p25–p34.

Management of Subclinical Hypothyroidism: The Thyroidologists’ View

OPN -443C>T Genetic Polymorphism and Tumor OPN Expression are Associated with the Risk and Clinical Features of Papillary Thyroid Cancer in a Chinese Cohort.

The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent.

Biochemical Predictors of Outcome of Pituitary Surgery for Cushing’s Disease Neuroendocrinology 2010;91:169–178 - DOI: / © 2009 S. Karger.

Can the American Thyroid Association Risk of Recurrence Predict Radioiodine Refractory Disease in Differentiated Thyroid Cancer Eur Thyroid J 2016;5:

Am J Nephrol 2013;38: DOI: / Fig. 1. Study selection process.

Quantitative Analysis of Abdominal Aortic Calcification in CKD Patients Without Dialysis Therapy by Use of the Agatston Score Kidney Blood Press Res 2013;38:

A Review of the Use of Biotin for Hair Loss

The Clinical Significance of Uric Acid and Complement Activation in the Progression of IgA Nephropathy Kidney Blood Press Res 2016;41: DOI: /

Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study Liver Cancer.

Effectiveness and Cost-Effectiveness of Dialectical Behaviour Therapy for Self-Harming Patients with Personality Disorder: A Pragmatic Randomised Controlled.

Diabetic Cardiovascular Disease Predicts Chronic Kidney Disease Awareness in the Kidney Early Evaluation Program Cardiorenal Med 2011;1:45–52 - DOI: /

Metastatic Castration-Resistant Prostate Cancer: Two Case Reports of Dramatic Response with Abiraterone Acetate in Patients Heavily Pretreated with Chemotherapy.

Creatinine-Based Glomerular Filtration Rates and Microalbuminuria for Detecting Metabolic Abnormalities in US Adults: The National Health and Nutrition.

Potential Contributions of Heat Shock Proteins to Temperature-Dependent Sex Determination in the American Alligator Sex Dev 2010;4:73–87 - DOI: /

Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment Liver.

Plasma Cell Leukemia Presenting as a Chest Wall Mass: A Case Report

Oncol Res Treat 2016;39: DOI: /

T-Cell Lymphoma in a Patient with Neurofibromatosis Type 1 and AIDS

The Role of Radical Prostatectomy and Radiotherapy in Treatment of Locally Advanced Prostate Cancer: A Systematic Review and Meta-Analysis Urol Int 2017;99:

Determinants of Overweight and Obesity in Lung Transplant Recipients

Prophylactic Antibiotics Reduce Pancreatic Necrosis in Acute Necrotizing Pancreatitis: A Meta-Analysis of Randomized Trials Dig Surg 2010;27:442–449 -

The Impact of Case Finding on the Recruitment Yield for COPD Research in Primary Care: An Observational Study Respiration 2016;92: DOI: /

Acta Haematol 2013;129:207– DOI: /

A Prospective Study Showing an Excellent Response of Patients with Low-Risk Differentiated Thyroid Cancer Who Did Not Undergo Radioiodine Remnant Ablation.

Evaluating Quality in Clinical Cancer Research: The M. D

Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients Am J Nephrol 2017;45: DOI: /

Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World.

Overview of Chromosome Abnormalities in First Trimester Miscarriages: A Series of 1,011 Consecutive Chorionic Villi Sample Karyotypes Cytogenet Genome.

Electrochemotherapy in the Treatment of Massive, Multisite Breast Cancer Metastasis to the Skin and Subcutaneous Tissue: A Case Report Breast Care 2016;11:

The Effect of Upper Airway Surgery on Continuous Positive Airway Pressure Levels and Adherence: A Systematic Review and Meta-Analysis ORL 2016;78:

Cord Blood IL-16 Is Associated with 3-Year Neurodevelopmental Outcomes in Perinatal Asphyxia and Hypoxic-Ischaemic Encephalopathy Dev Neurosci 2017;39:59-65.

Combination Chemotherapy of Azacitidine and Cetuximab for Therapy-Related Acute Myeloid Leukemia following Oxaliplatin for Metastatic Colorectal Cancer.

Cell Physiol Biochem 2016;38: DOI: /

Margaret L. Gulley, Thomas C. Shea, Yuri Fedoriw

DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic.

Plasma Glycated Albumin Levels Clearly Detect Hearing Loss and Atherosclerosis in Patients with Impaired Fasting Glucose Med Princ Pract 2016;25:

Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia

Anthracycline Dose Intensification in Acute Myeloid Leukemia

Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis Neuroepidemiology 2015;44: DOI: /

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic.

Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients Breast Care 2016;11: DOI: / Fig. 1. Strategies.

A Pathological Scoring System to Predict Renal Outcome in Diabetic Nephropathy Am J Nephrol 2015;41: DOI: / Fig. 1. Renal survival.

Volume 17, Issue 1, Pages (January 2010)

Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia by Masahiro Sakaguchi, Hiroki Yamaguchi, Yuho Najima, Kensuke.

NPM1 mutated AML can relapse with wild-type NPM1: persistent clonal hematopoiesis can drive relapse by Alexander Höllein, Manja Meggendorfer, Frank Dicker,

Short title / Key scientific finding

A New Therapeutic Target for Leukemia Comes to the Surface

Emerging Importance of Mutational Analysis in Myelodysplastic Syndrome and Acute Myelogenous Leukemia Aaron T. Gerds, Matthew J. Walter, Bart L. Scott

Central Nervous System Involvement in Acute Myeloid Leukemia Patients Undergoing Hematopoietic Cell Transplantation Merav Bar, Weigang Tong, Megan Othus,

Favorable Outcome in Patients with Acute Myelogenous Leukemia with the Nucleophosmin Gene Mutation Autografted after Conditioning with High-Dose Continuous.

Minimal Residual Disease and Hematologic Malignancies

Digital Medicine: A Primer on Measurement

Transplants Facilitated by NMDP/Be The Match

Presentation transcript:

Clinical Implications of Non-A-Type<i> NPM1</i> and <i>FLT3</i> Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Acta Haematol 2012;127:63–71 - DOI:10.1159/000331509 Fig. 1.a RFS in patients with AML-NK according to NPM1 and FLT3-ITDmut. b OS of patients with AML-NK according to NPM1 and FLT3-ITDmut. Patients with NPM1mut but without FLT3-ITDmut had significantly better RFS and OS than other patient groups. NPM1mut/FLT3wt: patients with NPM1mut without FLT3-ITDmut; NPM1mut/FLT3mut: patients with both NPM1 and FLT3-ITDmut; NPM1wt/FLT3wt: patients with neither NPM1 nor FLT3-ITDmut; NPM1wt/FLT3mut: patients with FLT3-ITDmut without NPM1mut. © 2011 S. Karger AG, Basel

Clinical Implications of Non-A-Type<i> NPM1</i> and <i>FLT3</i> Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Acta Haematol 2012;127:63–71 - DOI:10.1159/000331509 Fig. 1.a RFS in patients with AML-NK according to NPM1 and FLT3-ITDmut. b OS of patients with AML-NK according to NPM1 and FLT3-ITDmut. Patients with NPM1mut but without FLT3-ITDmut had significantly better RFS and OS than other patient groups. NPM1mut/FLT3wt: patients with NPM1mut without FLT3-ITDmut; NPM1mut/FLT3mut: patients with both NPM1 and FLT3-ITDmut; NPM1wt/FLT3wt: patients with neither NPM1 nor FLT3-ITDmut; NPM1wt/FLT3mut: patients with FLT3-ITDmut without NPM1mut. © 2011 S. Karger AG, Basel

Clinical Implications of Non-A-Type<i> NPM1</i> and <i>FLT3</i> Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Acta Haematol 2012;127:63–71 - DOI:10.1159/000331509 Fig. 2.a RFS of patients with NPM1mut according to the type of NPM1mut. b OS of patients with NPM1mut according to the type of NPM1mut. No significant differences in survival outcomes were detected between patients with A-type and non-A-type NPM1mut. c RFS of patients with A-type NPM1mut according to FLT3mut. d OS of patients with A-type NPM1mut according to FLT3mut. No significant differences were detected in survival between patients with FLT3wt and FLT3mut. e RFS of patients with non-A-type NPM1mut according to FLT3mut. The RFS was significantly increased in patients with FLT3wt compared to patients with FLT3mut.f OS of patients with non-A-type NPM1 mut according to FLT3mut. © 2011 S. Karger AG, Basel

Clinical Implications of Non-A-Type<i> NPM1</i> and <i>FLT3</i> Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Acta Haematol 2012;127:63–71 - DOI:10.1159/000331509 Fig. 2.a RFS of patients with NPM1mut according to the type of NPM1mut. b OS of patients with NPM1mut according to the type of NPM1mut. No significant differences in survival outcomes were detected between patients with A-type and non-A-type NPM1mut. c RFS of patients with A-type NPM1mut according to FLT3mut. d OS of patients with A-type NPM1mut according to FLT3mut. No significant differences were detected in survival between patients with FLT3wt and FLT3mut. e RFS of patients with non-A-type NPM1mut according to FLT3mut. The RFS was significantly increased in patients with FLT3wt compared to patients with FLT3mut.f OS of patients with non-A-type NPM1 mut according to FLT3mut. © 2011 S. Karger AG, Basel

Clinical Implications of Non-A-Type<i> NPM1</i> and <i>FLT3</i> Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Acta Haematol 2012;127:63–71 - DOI:10.1159/000331509 Fig. 2.a RFS of patients with NPM1mut according to the type of NPM1mut. b OS of patients with NPM1mut according to the type of NPM1mut. No significant differences in survival outcomes were detected between patients with A-type and non-A-type NPM1mut. c RFS of patients with A-type NPM1mut according to FLT3mut. d OS of patients with A-type NPM1mut according to FLT3mut. No significant differences were detected in survival between patients with FLT3wt and FLT3mut. e RFS of patients with non-A-type NPM1mut according to FLT3mut. The RFS was significantly increased in patients with FLT3wt compared to patients with FLT3mut.f OS of patients with non-A-type NPM1 mut according to FLT3mut. © 2011 S. Karger AG, Basel

Clinical Implications of Non-A-Type<i> NPM1</i> and <i>FLT3</i> Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Acta Haematol 2012;127:63–71 - DOI:10.1159/000331509 Fig. 2.a RFS of patients with NPM1mut according to the type of NPM1mut. b OS of patients with NPM1mut according to the type of NPM1mut. No significant differences in survival outcomes were detected between patients with A-type and non-A-type NPM1mut. c RFS of patients with A-type NPM1mut according to FLT3mut. d OS of patients with A-type NPM1mut according to FLT3mut. No significant differences were detected in survival between patients with FLT3wt and FLT3mut. e RFS of patients with non-A-type NPM1mut according to FLT3mut. The RFS was significantly increased in patients with FLT3wt compared to patients with FLT3mut.f OS of patients with non-A-type NPM1 mut according to FLT3mut. © 2011 S. Karger AG, Basel

Clinical Implications of Non-A-Type<i> NPM1</i> and <i>FLT3</i> Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Acta Haematol 2012;127:63–71 - DOI:10.1159/000331509 Fig. 2.a RFS of patients with NPM1mut according to the type of NPM1mut. b OS of patients with NPM1mut according to the type of NPM1mut. No significant differences in survival outcomes were detected between patients with A-type and non-A-type NPM1mut. c RFS of patients with A-type NPM1mut according to FLT3mut. d OS of patients with A-type NPM1mut according to FLT3mut. No significant differences were detected in survival between patients with FLT3wt and FLT3mut. e RFS of patients with non-A-type NPM1mut according to FLT3mut. The RFS was significantly increased in patients with FLT3wt compared to patients with FLT3mut.f OS of patients with non-A-type NPM1 mut according to FLT3mut. © 2011 S. Karger AG, Basel

Clinical Implications of Non-A-Type<i> NPM1</i> and <i>FLT3</i> Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Acta Haematol 2012;127:63–71 - DOI:10.1159/000331509 Fig. 2.a RFS of patients with NPM1mut according to the type of NPM1mut. b OS of patients with NPM1mut according to the type of NPM1mut. No significant differences in survival outcomes were detected between patients with A-type and non-A-type NPM1mut. c RFS of patients with A-type NPM1mut according to FLT3mut. d OS of patients with A-type NPM1mut according to FLT3mut. No significant differences were detected in survival between patients with FLT3wt and FLT3mut. e RFS of patients with non-A-type NPM1mut according to FLT3mut. The RFS was significantly increased in patients with FLT3wt compared to patients with FLT3mut.f OS of patients with non-A-type NPM1 mut according to FLT3mut. © 2011 S. Karger AG, Basel